Early research (Phase 1)Looking for participantsNCT07619820
What this trial is testing
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
Who this might be right for
End Stage Kidney Disease (ESKD)
CSL Behring 24